Abstract:Elevated levels of MMP‐1, MMP‐2, MMP‐3, OPN, and TSLP were detected at sites affected by periodontitis and peri‐implantitis compared to sites with healthy teeth and implants. The cytokine OPN may serve as a biomarker for periodontitis, whereas the proteolytic enzyme MMP‐2 and the cytokine TSLP might be potential biomarkers for both periodontitis and peri‐implantitis. Aim Periodontitis and peri‐implantitis are chronic inflammatory diseases characterized by the destruction of supporting tissues. Despite some similarities, it is essential to understand the differences in how these diseases elicit unique host responses within the oral tissues, including the production of selected matrix metalloproteinases (MMPs) and inflammatory mediators involved in tissue remodelling. The aim of this study was to evaluate the levels of proteolytic enzymes MMP‐1, MMP‐2, MMP‐3, as well as the inflammatory mediators osteopontin (OPN), pentraxin‐3 (PTX3), and thymic stromal lymphopoietin (TSLP) in crevicular fluid samples collected from healthy, periodontitis‐affected, and peri‐implantitis sites. Methods Gingival crevicular fluid (GCF) and peri‐implant crevicular fluid (PICF) samples were collected from healthy and diseased teeth and implant sites of 163 patients. The MMP‐1, MMP‐2, MMP‐3, OPN, PTX3, and TSLP levels were determined using commercially available immunoassays. A linear mixed model procedure was adopted for multilevel analyses, using biomarker levels as the outcome variable to compare two types of sites. The diagnostic accuracy of the biomarkers was evaluated by Youden's index to estimate the sensitivity, specificity and the area under curve (AUC). Results The levels of MMP‐1, MMP‐2, MMP‐3, OPN, and TSLP were higher at sites with periodontitis and peri‐implantitis compared to the levels at sites with healthy teeth and healthy implants. No significant differences were observed in the levels of the measured markers between the sites diagnosed with periodontitis and those diagnosed with peri‐implantitis. The highest diagnostic potential at implant sites was found for MMP‐2 (AUC = 0.74) and TSLP (AUC = 0.72). The highest AUC (0.82) at tooth sites was found for OPN. Conclusions The findings indicate that the proteolytic enzyme MMP‐2 and the cytokine TSLP might be potential biomarkers for both periodontitis and peri‐implantitis, whereas the proinflammatory cytokine OPN may serve as a biomarker for periodontitis. Further studies are required to confirm the utility of these biomarkers and explore their potential clinical applications.

Accuracy of Gingival Crevicular Fluid Biomarkers of MMP8, TIMP1, RANK, RANKL, and OPG in Differentiating Symptomatic and Asymptomatic Apical Periodontitis

Expressions of MMP-8 and TIMP-1 in Gingival Tissue of Patients with Aggressive Periodontitis

aMMP-8 POCT vs. Other Potential Biomarkers in Chair-Side Diagnostics and Treatment Monitoring of Severe Periodontitis

Matrix metalloproteinase 9 level changes in gingival crevicular fluid samples of teeth with acute and chronic apical periodontitis

Biomarker Levels in Gingival Crevicular Fluid of Subjects with Different Periodontal Conditions: A Cross-Sectional Study

MMP-7 and TIMP-1, new targets in predicting poor wound healing in apical periodontitis

Myeloid-related protein (MRP8/14) expression in gingival crevice fluid in periodontal health and disease and after treatment

Diagnostic accuracy of a point‐of‐care aMMP‐8 test in the discrimination of periodontal health and disease

Elevated Cytokine Levels in Gingival Crevicular Fluid of Teeth with Apical Periodontitis

Active Matrix Metalloproteinase-8 (aMMP-8) Versus Total MMP-8 in Periodontal and Peri-Implant Disease Point-of-Care Diagnostics

Matrix metalloproteinase-8 levels in oral samples as a biomarker for periodontitis in the Chinese population: an observational study

Cytokine expression of IL-8 before and after root canal treatment in patients with symptomatic apical periodontitis: A clinical trial

Diagnostic value of aMMP-8 and azurocidin in peri-implant sulcular fluid as biomarkers of peri-implant health or disease

Levels of matrix metalloproteinase‐1 (MMP‐1), MMP‐2, MMP‐3, osteopontin, pentraxin‐3, and thymic stromal lymphopoietin in crevicular fluid samples from peri‐implantitis, periodontitis, and healthy sites

Expression of IL-1β, IL-6, TNF-α, and a-MMP-8 in sites with healthy conditions and with periodontal and peri-implant diseases: A case-control study

Evaluation of Salivary Biomarkers for the Diagnosis of Periodontitis

Diagnostic potential and future directions of matrix metalloproteinases as biomarkers in gingival crevicular fluid of oral and systemic diseases

Diagnostic accuracy of active matrix metalloproteinase-8 point-of-care test for the discrimination of periodontal health status: Comparison of saliva and oral rinse samples

Periodontal Treatment Reduces Matrix Metalloproteinase Levels in Localized Aggressive Periodontitis

In Vivo Regulation of Active Matrix Metalloproteinase-8 (aMMP-8) in Periodontitis: From Transcriptomics to Real-Time Online Diagnostics and Treatment Monitoring